Chargement en cours...
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
OBJECTIVE: Increased hepatic de novo lipogenesis (DNL) is suggested to be an underlying cause in the development of nonalcoholic fatty liver disease and/or insulin resistance. It is suggested that omega-3 fatty acids (FA) lower hepatic DNL. We investigated the effects of omega-3 FA supplementation o...
Enregistré dans:
| Publié dans: | BMJ Open Diabetes Res Care |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078804/ https://ncbi.nlm.nih.gov/pubmed/32188593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000871 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|